Oryzon Genomics S.A.
ORYZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $6 | $12 | $21 | $29 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $2 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $0 | $3 | $2 |
| Total Curr. Assets | $9 | $14 | $25 | $33 |
| Property Plant & Equip (Net) | $0 | $0 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $97 | $0 | $76 | $60 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $2 | $2 | $2 | $2 |
| Other NC Assets | $0 | $90 | $0 | $0 |
| Total NC Assets | $100 | $93 | $79 | $63 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $109 | $107 | $104 | $95 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $5 | $3 |
| Short-Term Debt | $8 | $10 | $10 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $3 | $3 | $2 |
| Total Curr. Liab. | $12 | $16 | $19 | $9 |
| LT Debt | $3 | $3 | $7 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $2 | $2 | $2 | $2 |
| Other NC Liab. | $4 | $3 | $3 | $3 |
| Total NC Liab. | $10 | $9 | $12 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22 | $25 | $31 | $24 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$19 | -$16 | -$12 | -$8 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $103 | $94 | $82 | $77 |
| Total Equity | $87 | $82 | $73 | $71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $109 | $107 | $104 | $95 |
| Net Debt | $6 | $1 | -$4 | -$15 |